POST Online Media Lite Edition


Zealand Pharma appoints Frank Sanders as U.S. president

Christian Fernsby |
Copenhagen, Denmark - Zealand Pharma, a biotechnology company, announced the appointment of Frank Sanders as president of Zealand Pharma U.S.

Article continues below

Mr. Sanders has extensive experience in leading multidisciplinary operational teams to achieve successfully their growth strategies.

Mr. Sanders will be a member of the international corporate management team.

Prior to joining Zealand Pharma, Mr. Sanders served as the general manager of the U.S. Commercial team at Sage Therapeutics.

Earlier experience was gained through roles of increasing commercial responsibilities at Janssen and GlaxoSmithKline.


BioMar announces new global director of R&D
BioMar appoints managing director in Australia
BioMar announces new top management in the salmon division
BioMar icon Niels Alsted retires after 45 years in aquaculture
Arla Foods appoints Heléne Gunnarson as vice-chairman